Equities

ADDvise Group AB (publ)

ADDvise Group AB (publ)

Actions
  • Price (SEK)9.82
  • Today's Change-2.18 / -18.17%
  • Shares traded14.74k
  • 1 Year change-25.04%
  • Beta0.3868
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ADDvise Group AB, formerly ADDvise Lab Solutions publ AB, is a Sweden-based company principally engaged in the supply of fittings, equipment and safety ventilation for laboratory environments. The Company’s service range also includes the delivery, installation, furnishing and validation of clean rooms. The Company’s operations are divided into two business areas, namely ADDvise KEBO and ADDvise Tillquist. The ADDvise KEBO area focuses on the furnishings and protective ventilation. The ADDvise Tillquist area focuses on laboratory equipment, supplies and wave technologies. Additionally, it operates under such brand names, as ADDvise, KEBO Inredningar and Tillquist. As of December 31, 2011, it had three wholly owned subsidiaries, such as KEBO Inredningar Sverige AB, ADDvise Tillquist AB and addVise internordic AB, as well as held 50% shares of advise Ltd.

  • Revenue in SEK (TTM)1.63bn
  • Net income in SEK114.40m
  • Incorporated1989
  • Employees643.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ADDV A:STO since
announced
Transaction
value
Labplan LtdDeal completed22 Dec 202322 Dec 2023Deal completed-27.79%--
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ContextVision AB129.73m21.74m393.61m41.0018.114.1213.083.030.28120.28121.681.241.132.364.823,246,404.0018.8929.3923.7943.2796.8398.5816.7627.154.57--0.017--12.197.78-1.77---35.88--
Nexstim Oyj91.75m-9.65m404.45m39.00--18.69--4.41-0.1223-0.12231.190.27610.81960.22235.28214,040.30-8.62-26.77-14.02-43.9097.2492.11-10.52-38.381.24-5.510.7716---23.9422.08-201.58--19.51--
BrainCool AB (publ)37.48m-57.58m407.96m20.00--2.65--10.89-0.2635-0.26350.16950.60710.23782.013.761,561,500.00-36.54-47.14-39.83-70.16-32.65-149.77-153.65-391.453.64-5.860.00--32.0678.35-34.34---11.63--
Integrum AB102.18m-2.52m422.03m36.00--2.35556.824.13-0.1244-0.12445.299.580.57060.56663.592,620,068.00-1.41-1.71-1.55-1.9887.2583.87-2.47-2.875.54-0.66360.0325--40.1935.91124.92--127.10--
Bioretec Oy47.22m-40.90m428.82m43.00--5.72--9.08-0.1752-0.17520.20240.3180.41041.233.75110,166.80-35.54-66.83-40.92-97.1969.9770.97-86.61-133.494.04--0.0696--32.7819.77-54.02------
Modulight Oyj39.96m-137.30m454.24m79.00--0.7545--11.37-0.2844-0.28440.08361.220.0516-0.31111.9449,271.43-17.72-8.39-18.97-9.10123.49114.69-343.58-56.814.50--0.0965---12.48-8.20-38.69--63.60--
Mentice AB274.55m-23.28m536.95m130.00--3.87172.321.96-0.9104-0.910410.715.420.92432.774.382,250,394.00-7.84-7.69-15.21-13.0785.8983.67-8.48-10.000.9251--0.0285--25.5411.7490.81---10.83--
Gentian Diagnostics ASA146.78m2.22m631.69m58.00324.803.9255.744.300.12620.12629.3510.470.77921.698.402,533,190.001.18-10.761.33-11.8651.6941.461.51-26.995.01--0.0394--32.9827.6354.92---4.92--
Omda AS420.67m-25.98m647.42m271.00--10.2422.781.54-1.27-1.2720.923.030.584737.9313.471,447,038.00-3.83-4.92-7.72-6.3793.0790.22-6.55-9.831.150.06810.8875--12.3019.83179.30---3.93--
Senzime AB (publ)55.29m-131.46m649.41m52.00--2.41--11.74-1.09-1.090.45952.380.15331.574.91---36.44-35.69-39.12-38.0033.27-20.59-237.75-558.682.62--0.0739--154.7761.90-1.09---3.69--
ADDvise Group AB (publ)1.63bn114.40m752.08m643.0020.223.053.570.46250.59350.59358.383.930.5658.375.772,606,250.003.983.724.824.7742.0748.957.045.891.402.350.69690.940544.3038.6227.62--30.35--
OssDsign AB127.49m-90.44m776.39m25.00--3.62--6.09-1.00-1.001.352.200.40331.325.962,656,063.00-28.61-37.92-31.51-43.5688.6468.10-70.94-203.065.44-20.450.01--96.8453.26-31.30---56.16--
Optomed Oyj157.57m-69.40m901.75m113.00--3.15--5.72-0.3355-0.33550.7631.260.42671.754.06119,307.00-18.79-12.95-22.82-15.9064.8065.69-44.04-27.842.76-20.420.1313--3.003.4718.84--7.26--
C Rad AB497.02m53.43m913.09m94.0017.533.1014.591.841.581.5814.728.961.235.042.725,712,816.0013.255.0919.167.0246.3043.1210.814.862.32--0.00490.0040.9217.44375.0510.8933.69--
Bactiguard Holding AB254.96m-56.11m1.07bn163.00--3.67--4.19-1.60-1.607.289.370.37063.847.601,174,917.00-8.16-7.56-11.32-8.8147.5347.91-22.01-26.280.5898-2.720.4175---11.966.46-161.71--8.43--
Data as of Nov 22 2024. Currency figures normalised to ADDvise Group AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Acadian Asset Management LLCas of 30 Sep 20230.000.00%
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.